- Home
- FLNT vs ATNM Comparison
FLNT vs ATNM Comparison
Compare FLNT & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLNT
- ATNM
- Stock Information
- Founded
- FLNT 2001
- ATNM 2000
- Country
- FLNT United States
- ATNM United States
- Employees
- FLNT N/A
- ATNM N/A
- Industry
- FLNT Advertising
- ATNM Biotechnology: Pharmaceutical Preparations
- Sector
- FLNT Consumer Discretionary
- ATNM Health Care
- Exchange
- FLNT Nasdaq
- ATNM Nasdaq
- Market Cap
- FLNT 53.4M
- ATNM 49.0M
- IPO Year
- FLNT N/A
- ATNM N/A
- Fundamental
- Price
- FLNT $2.23
- ATNM $1.73
- Analyst Decision
- FLNT Hold
- ATNM Strong Buy
- Analyst Count
- FLNT 1
- ATNM 2
- Target Price
- FLNT $3.00
- ATNM $4.50
- AVG Volume (30 Days)
- FLNT 2.0M
- ATNM 142.5K
- Earning Date
- FLNT 08-19-2025
- ATNM 08-08-2025
- Dividend Yield
- FLNT N/A
- ATNM N/A
- EPS Growth
- FLNT N/A
- ATNM N/A
- EPS
- FLNT N/A
- ATNM N/A
- Revenue
- FLNT $229,839,000.00
- ATNM N/A
- Revenue This Year
- FLNT N/A
- ATNM N/A
- Revenue Next Year
- FLNT $2.01
- ATNM N/A
- P/E Ratio
- FLNT N/A
- ATNM N/A
- Revenue Growth
- FLNT N/A
- ATNM N/A
- 52 Week Low
- FLNT $1.50
- ATNM $1.03
- 52 Week High
- FLNT $3.83
- ATNM $2.41
- Technical
- Relative Strength Index (RSI)
- FLNT 52.21
- ATNM 58.43
- Support Level
- FLNT $1.70
- ATNM $1.66
- Resistance Level
- FLNT $2.93
- ATNM $1.81
- Average True Range (ATR)
- FLNT 0.30
- ATNM 0.11
- MACD
- FLNT 0.00
- ATNM 0.02
- Stochastic Oscillator
- FLNT 47.22
- ATNM 88.94
About FLNT Fluent Inc.
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.